Aptevo Therapeutics Inc. Accrued Liabilities and Other Liabilities
Aptevo Therapeutics Inc. (APVO) had Accrued Liabilities and Other Liabilities of $3.11 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities and Other Liabilities $3.11M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $2.98M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $4.31M.
- 2024-12-31: Accrued Liabilities and Other Liabilities $4.20M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2026-06-30 | $3.11M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.98M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.31M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $4.20M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |